Business Update3 Jun 2026, 09:11 pm
AstraZeneca Pharma India Surrenders Factory License
AI Summary
AstraZeneca Pharma India Ltd has announced the surrender of its factory license to the Department of Factories, Boilers, Industrial Safety and Health for cancellation. The license was valid until December 31, 2026. This action follows previous intimations regarding the exit from the manufacturing site and the surrender of the manufacturing license. The company has provided details as required by SEBI regulations.
Key Highlights
- AstraZeneca Pharma India surrenders its factory license.
- License was valid until December 31, 2026.
- Action follows previous site exit and license surrender.
- Details provided as per SEBI regulations.
Price Impact
More from ASTRAZEN